qz
Sionna Therapeutics stock plunged 92% after its cystic fibrosis drug flopped in a mid-stage trial

The biotech said it will not advance SION-719 as an add-on therapy after the drug missed its key endpoint in a Phase 2a study [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
Most enterprises can't stop stage-three AI agent threats, VentureBeat survey finds

A rogue AI agent at Meta passed every identity check and still exposed sensitive data to unauthorized employees in March. Two weeks later, Mercor, a $10 billion AI startup, confirmed a supply-chain br [...]

Match Score: 81.21

Destination
How a 1980s Atari creator with cystic fibrosis crafted a story of salmon survival

Doctors said he'd die by 13, but Bill Williams turned long odds into iconic art about endurance. [...]

Match Score: 64.07

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 42.66

venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]

Match Score: 39.38

Destination
What we’ve learned from FTC v. Meta antitrust trial

Meta is facing its biggest existential threat in its history. Years after the Federal Trade Commission first sued the social network in an attempt to unwind its acquisitions of Instagram and WhatsApp, [...]

Match Score: 38.11

Destination
Mark Zuckerberg testifies in social media addiction trial that Meta just wants Instagram to be 'useful'

Mark Zuckerberg took the stand Wednesday in a high-profile jury trial over social media addiction. In an appearance that was described by NBC News as "combative," the Facebook founder report [...]

Match Score: 37.71

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 36.06

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 36.06

venturebeat
RAG precision tuning can quietly cut retrieval accuracy by 40%, putting agentic pipelines at risk

Enterprise teams that fine-tune their RAG embedding models for better precision may be unintentionally degrading the retrieval quality those pipelines depend on, according to new research from Redis.T [...]

Match Score: 35.24